Post-stroke depression and cognitive impairment: Study design and preliminary findings in a Brazilian prospective stroke cohort (EMMA study)

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP BACCARO, Alessandra FMUSP-HC
BRUNONI, Andre Russowsky FMUSP-HC
LEITE, Claudia da Costa FMUSP-HC
FILHO, Geraldo Busatto FMUSP-HC
GOULART, Alessandra Carvalho FMUSP-HC 2019
dc.identifier.citation JOURNAL OF AFFECTIVE DISORDERS, v.245, p.72-81, 2019
dc.identifier.issn 0165-0327
dc.description.abstract Background: Post-stroke depression (PSD) and cognitive impairment (PCI) are common conditions. This study aims to describe the protocol and preliminary findings of an investigation into factors associated with PSD and PCI 1-3 months after stroke (subacute phase) in survivors from the Study of Stroke Mortality and Morbidity (EMMA study). Methods: Stroke patients underwent to clinical and neurological evaluations on admission to hospital. Cerebral magnetic resonance and biomarkers (serotonin, BDNF, IL-6 and IL-18) were carried out in the subacute phase. DSM-IV major depression for the diagnosis of PSD, cognitive functioning for the diagnosis of PCI and functional disability were also recorded at same time. Results: Of the 103 eligible patients, 85.4% had ischemic stroke and 73.7% had first-ever stroke. In the subacute phase, 27.2% had PCI and 13.6% had current PSD (5.8% with 'first episode' and 7.8% with 'recurrent' depression). PCI was associated with low education (0-7 years of formal education: 75%) and ageing (median age: 70; interquartile range: 59-75 y-old). Left-sided stroke was more frequently associated with increased PCI than right-sided stroke (71.4% vs. 28.4%, p = 0.005). PSD was neither associated with stroke laterality nor tentorial area. Overall, biomarkers levels were not alterated in patients with PSD and PCI. Limitations: Findings are based on small sample and less disabled stroke participants, e.g. those without aphasia and deafness. Conclusions: Findings reinforce the need of early recognition and rehabilitation of PCI and PSD, mainly among those less educated and with left-sided stroke. PSD might occur through a pathophysiological pathway other than classical depression.
dc.description.sponsorship · Sao Paulo Research Foundation (FAPESP), Sao Paulo, SP, Brazil [2015/17321-0]
dc.language.iso eng
dc.relation.ispartof Journal of Affective Disorders
dc.rights restrictedAccess
dc.subject Stroke; Post-stroke depression; Cognitive impairment; Neuroimaging; Biomarkers
dc.subject.other transient ischemic attack; neurotrophic factor levels; mental-state-examination; lesion location; mood disorders; neurological disorders; telephone interview; 1st-ever stroke; dynamic changes; assessment moca
dc.title Post-stroke depression and cognitive impairment: Study design and preliminary findings in a Brazilian prospective stroke cohort (EMMA study)
dc.type article
dc.rights.holder Copyright ELSEVIER SCIENCE BV LIM/15 LIM/20 LIM/21 LIM/23 LIM/27 LIM/44 LIM/51
dc.identifier.doi 10.1016/j.jad.2018.10.003
dc.identifier.pmid 30368073
dc.type.category original article
dc.type.version publishedVersion BACCARO, Alessandra:FM: WANG, Yuan-Pang:HC:IPQ CONFORTO, Adriana Bastos:HC:ICHC BRUNONI, Andre Russowsky:HC:IPQ LEITE, Claudia da Costa:FM:MDR FILHO, Geraldo Busatto:FM:MPS LOTUFO, Paulo A.:FM:MCM BENSENOR, Isabela M.:FM:MCM GOULART, Alessandra Carvalho:HU:SCPACEX-62 · CANDIDO, Miriam:Univ Sao Paulo, Hosp Univ, Ctr Clin & Epidemiol Res, Av Prof Lineu Prestes 2565,Butantan Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil
· GOULART, Alessandra Carvalho:Univ Sao Paulo, Hosp Univ, Ctr Clin & Epidemiol Res, Av Prof Lineu Prestes 2565,Butantan Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil WOS:000456697100009 2-s2.0-85055257825 AMSTERDAM NETHERLANDS
hcfmusp.relation.reference · ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
· Almeida OP, 2007, AM J GERIAT PSYCHIAT, V15, P506, DOI 10.1097/01.JGP.0000246869.49892.77
· Baccaro A, 2015, GERIATR GERONTOL INT, V15, P1118, DOI 10.1111/ggi.12409
· Ballard C, 2003, STROKE, V34, P2440, DOI 10.1161/01.STR.0000089923.29724.CE
· Barber M, 2004, INT J GERIATR PSYCH, V19, P75, DOI 10.1002/gps.1041
· Bensimon K, 2014, NEUROPSYCH DIS TREAT, V10, P1827, DOI 10.2147/NDT.S65740
· BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001
· Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26
· Bossu P, 2009, CURR NEUROVASC RES, V6, P163, DOI 10.2174/156720209788970036
· Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9
· Carod-Artal F. J., 2006, REV NEUROL, V42, P794
· Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X
· Chan E, 2017, J NEUROL SCI, V373, P100, DOI 10.1016/j.jns.2016.12.028
· de Mello RF, 2016, J STROKE CEREBROVASC, V25, P618, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.021
· Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008
· Demeyere N, 2016, J NEUROL, V263, P306, DOI 10.1007/s00415-015-7964-4
· Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051
· Douven E, 2017, NEUROPSYCHOL REV, V27, P202, DOI 10.1007/s11065-017-9356-2
· Duro D, 2010, J NEUROL, V257, P728, DOI 10.1007/s00415-009-5399-5
· Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5
· Gao HQ, 2008, CLIN INVEST MED, V31, pE351
· Goulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x
· Ihle-Hansen H, 2011, DEMENT GERIATR COGN, V32, P401, DOI 10.1159/000335361
· Jimenez I, 2009, PSYCHOL MED, V39, P1201, DOI 10.1017/S0033291709005637
· Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7
· Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875
· Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
· Li J, 2014, J AFFECT DISORDERS, V168, P373, DOI 10.1016/j.jad.2014.07.011
· Lima MG, 1993, J BRASILEIRO PSIQUIA, V42, P255
· Mellon L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0288-2
· Mirza SS, 2016, LANCET PSYCHIAT, V3, P628, DOI 10.1016/S2215-0366(16)00097-3
· Mitchell AJ, 2017, GEN HOSP PSYCHIAT, V47, P48, DOI 10.1016/j.genhosppsych.2017.04.001
· Moran GM, 2014, EUR J NEUROL, V21, P1258, DOI 10.1111/ene.12469
· Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671
· Narushima K, 2003, J NEUROPSYCH CLIN N, V15, P422, DOI 10.1176/appi.neuropsych.15.4.422
· Oksala NKJ, 2009, J NEUROL NEUROSUR PS, V80, P1230, DOI 10.1136/jnnp.2009.174573
· Ormstad H, 2014, J MOL NEUROSCI, V54, P181, DOI 10.1007/s12031-014-0272-0
· Ormstad H, 2012, INT J NEUROSCI, V122, P682, DOI 10.3109/00207454.2012.709892
· Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x
· PARIKH RM, 1987, STROKE, V18, P579, DOI 10.1161/01.STR.18.3.579
· Pedroso VSP, 2016, CURR NEUROVASC RES, V13, P163, DOI 10.2174/1567202613666160219120114
· Pompili M, 2015, DRUG AGING, V32, P21, DOI 10.1007/s40266-014-0233-x
· Pompili M, 2012, CNS NEUROSCI THER, V18, P711, DOI 10.1111/j.1755-5949.2012.00364.x
· Prisnie JC, 2016, INT J PSYCHIAT MED, V51, P262, DOI 10.1177/0091217416652616
· ROBINSON RG, 1984, STROKE, V15, P510, DOI 10.1161/01.STR.15.3.510
· Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363
· Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016
· Rothenburg LS, 2010, J GERIATR PSYCH NEUR, V23, P199, DOI 10.1177/0891988710373598
· Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434
· Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x
· Shi Y, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00218
· Sivakumar L, 2017, INT J STROKE, V12, P264, DOI 10.1177/1747493016676612
· Spalletta G., 2015, J NEUROPSYCHIATRY CL, V25, P255
· Srikanth VK, 2004, NEUROLOGY, V63, P785, DOI 10.1212/01.WNL.0000137042.01774.33
· Stopa Sheila Rizzato, 2015, Rev. bras. epidemiol., V18, P170, DOI 10.1590/1980-5497201500060015
· Su JA, 2012, GEN HOSP PSYCHIAT, V34, P35, DOI 10.1016/j.genhosppsych.2011.09.020
· Tan HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173291
· TATEMICHI TK, 1994, NEUROLOGY, V44, P1885, DOI 10.1212/WNL.44.10.1885
· Ten Brink AF, 2017, J CLIN EXP NEUROPSYC, V39, P707, DOI 10.1080/13803395.2016.1262333
· Terroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242
· Villa RF, 2018, PHARMACOL THERAPEUT, V184, P131, DOI 10.1016/j.pharmthera.2017.11.005
· Wei N, 2015, J NEUROL, V262, P81, DOI 10.1007/s00415-014-7534-1
· Wong A, 2015, J CLIN EXP NEUROPSYC, V37, P1004, DOI 10.1080/13803395.2015.1038983
· Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552
· Yang LL, 2010, NEUROL RES, V32, P340, DOI 10.1179/016164110X12656393665080
· Zekry D, 2003, NEUROBIOL AGING, V24, P213, DOI 10.1016/S0197-4580(02)00066-0
dc.description.index MEDLINE
dc.identifier.eissn 1573-2517
hcfmusp.citation.scopus 12 Brasil
hcfmusp.scopus.lastupdate 2021-07-13

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account